CN106859585A - A kind of medical fibre Sigmoidoscope and preparation method thereof - Google Patents
A kind of medical fibre Sigmoidoscope and preparation method thereof Download PDFInfo
- Publication number
- CN106859585A CN106859585A CN201710088129.6A CN201710088129A CN106859585A CN 106859585 A CN106859585 A CN 106859585A CN 201710088129 A CN201710088129 A CN 201710088129A CN 106859585 A CN106859585 A CN 106859585A
- Authority
- CN
- China
- Prior art keywords
- fibro
- colonoscope
- antibacterial peptide
- sigmoidoscope
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes, colonoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Abstract
The present invention relates to a kind of medical fibre Sigmoidoscope and preparation method thereof.Scribbling one layer on the surface of the fibro-colonoscope has bactericidal action antibacterial peptide layer, and described antibacterial peptide has the function of preferably killing pathogenic entero becteria.Described fibro-colonoscope is prepared simply, with low cost, with preferable bactericidal effect, is suitable for large-scale popularization, can effectively reduce patient for cross-infection risk, it is therefore prevented that the generation of malpractice.
Description
Technical field
The invention belongs to area of medical devices, specifically, it is related to a kind of medical fibre Sigmoidoscope and preparation method thereof.
Background technology
Fibro-colonoscope is one kind of Sigmoidoscope.It is made up of optical glass fibre and interior mirror body and annex, can be to total colectomy
Line-of-sighted observation.Suitable for checking that colon is suspected to have the lesions such as polyp, tumour, ulcer, inflammation, unknown cause hemorrhagic focus.Match somebody with somebody
X-ray clysis with barium or barium gas double contrast radiograph are closed, the diagnostic level of colonic pathological change can be improved.The major complications of inspection are enterobrosis.
Fibro-colonoscope be applicable：Make the inspections and examinations of rectum, caecum, the colon ascendens, transverse colon, sigmoid colon, colon, and ileocecus etc.
Treatment, due to can directly visually see the lesion of each part mentioned above, so as to diagnose correct, reliable.There is endoscope live body to take
Model machine structure.
Because in checking process, fibro-colonoscope enters rectum by anus, until large intestine, medical worker's observation colon and
The inner case of large intestine, thus the various bacteriums during fibro-colonoscope inevitably contacts enteron aisle in diagnoses and treatment and affected part
Pathological tissues, to pipeline cause infection, therefore be necessary to carry out it after inspection is finished targetedly thoroughly cleaning, with ensure
The clean and safe of each diagnoses and treatment, it is to avoid cross-infection occurs.Current cleaning method is that fibro-colonoscope is put into cleaning
Cleaning and sterilizing in pond or washing and disinfecting machine, but mirror body internal corners still there may be remnants patient's body in pathogen simultaneously
Thoroughly killing action can not be played.
A kind of detergent of fibro-colonoscope is disclosed in the A of CN 104498228, by the raw material system of following weight
It is standby to form：78 parts of water, four (3,5- di-t-butyl -4- hydroxyls) 25-27 parts of benzenpropanoic acid pentaerythritol esters, 0,0- dimethyl-S- (first
Base carbamoyl methyl) phosphorodithioate 20-22 parts, 26-28 parts of 3- (2,4_ 3,5-dimethylphenyl) -2- acrylic acid, 2,2- bis-
Methyl isophthalic acid-propyl alcohol 16-18 parts, 2,2_ 12-15 parts of dimethyl -1- propyl alcohol diisooctyl succinate sodium sulfonates, the tertiary fourth oxygen of (S)-N-
6-8 parts of carbonyl -2- benzene glycinols, 8-10 parts of 4- acetylaminohydroxyphenylarsonic acid 2 hydroxybenzoic acids, 1- (4- fluorophenyls) -4- [4- (4- chlorobenzenes
Base) the light base -1- piperidyls of -4-] 4-6 parts of -1- butanone.Although the detergent is going in stain and sterilization on both side to ensure fiber colon
The cleaning effect of mirror, but remain the bad defect of bactericidal effect.
Antibacterial peptide is the small polypeptide that a class has very strong bactericidal effect to bacterium, since the eighties in last century, antibacterial peptide
One of constituent as the biological innate immunity start behave find and recognize constantly have new antibacterial peptide thereafter each
Kind biology in find and be considered as anti-infective therapy future drugs.It has carrying positive charge, few resistance, fungicidal spectrum
Extensively, species it is various, to the low feature of mammalian cell toxicity.The mechanism of action of antibacterial peptide is different from traditional antibiotic, disease
Opportunistic pathogen is difficult to produce drug resistance to it, and some antibacterial peptides have very strong bactericidal activity to it, therefore is expected to be killed using antibacterial peptide
The infection of bacterium particularly pathogenic entero becteria.And the antibacterial peptide is used for the coating of the skin covering of the surface of fibro-colonoscope, you can realize
The effect of the surface disinfection of fibro-colonoscope.
The content of the invention
A kind of defect that the purpose of the present invention exists aiming at prior art, there is provided simple structure, it is reasonable in design, prevent
The cross-infection of remaining pathogenic bacteria during fibercolonscopy, prevents fibro-colonoscope from carrying the cross-infection of germ.
An object of the present invention is to provide a kind of anti-infective and suppression bacterium formation the carrying sustained-release antimicrobial peptide of strength to apply
Layer medical fibre Sigmoidoscope.
The second object of the present invention is to provide a kind of manufacture method of carrying sustained-release antimicrobial peptide coating medical fibre Sigmoidoscope.
What the present invention was realized in：A kind of carrying sustained-release antimicrobial peptide coating medical fibre Sigmoidoscope, including fibro-colonoscope
Body, it is characterised in that：The surfaces externally and internally of the fibro-colonoscope is coated with antibacterial peptide slow release layer, the antibacterial peptide slow release layer
To be combined with antibacterial peptide polymer coating.
Above-mentioned antibiotic slow release layer thickness is 5-30 μm.
One of technical scheme of the invention provides a kind of preparation method of fibro-colonoscope antibacterial surface coating of peptides, will
The body of fibro-colonoscope immerses the aqueous solution of polyethyleneimine, and the concentration of polyethyleneimine is 5-10mg/ml in the aqueous solution,
Soaked 40 minutes containing reciprocating vibration in 0.14mol/LNaCl, polymer base coat can be formed in the surfaces externally and internally of fibro-colonoscope；So
Be placed in that 100mL mass percent concentrations are 0.01% afterwards 4, react 5 hours in the methanol solution of 4 '-Diphenyl disulfide alcohol, instead
Fibro-colonoscope after answering is vacuum dried after fully being embathed through methyl alcohol, with antibacterial peptide respectively in horseradish peroxidase and peroxidating
The lower reaction of hydrogen effect, obtains the fibro-colonoscope of surface bond antibacterial polypeptide.When fibro-colonoscope is contacted with bacterial cell, pipe
The disulfide bonds in sublist face, reduction release polypeptide, play bactericidal action.
Described antibacterial peptide is that applicant's early stage screens acquisition, and its sequence is as follows：
KJT1：NTIWIPRRPHWQYWSQHWNTSPMTGLR
KJT2：QFFLQCGGGWVCSAHAWWMTRWWSQQR；
KJT3：WKHWGTIILNYEFRMNIAECFSGHDS；
KJT4：RLTWYPIYPMCHWCASAMYQYHHWLHQ；
KJT5：LSQVPGFIPMTHTRLQWLPVGPDQTRS；
KJT6：DRQHAATAQSLSLQYARFLVSWEQNNQ；
KJT7：RIEYHHNQYVTDVCSWQHKWDERGPWP；
The beneficial effects of the present invention are：Fibro-colonoscope with antibacterial peptide coating prepared by this method, with preventing
Fibro-colonoscope carries the germ in patient's body after use in vivo, and then causes other cross-patient contaminations to cause inflammation to be sent out
Raw risk, with great application prospect and important social value value.Sterilization can be saved with the popularization of large area
Cost, and reduce medical-risk.
Specific embodiment
The preparation of the fibro-colonoscope coat of embodiment 1
Fibro-colonoscope is cleaned by ultrasonic 5 minutes, 10 points in distilled water, acetone, 70% ethanol, ultra-pure water successively respectively
Clock, 10 minutes, after 5 minutes, then with ethane peroxide suffocating sterilization process after, immerse polyethyleneimine the aqueous solution, the aqueous solution
The concentration of middle polyethyleneimine is 10mg/ml, and reciprocating vibration soaks 40 minutes in NaCl containing 0.14mol/L, can be in gastroscope pipe
Surfaces externally and internally formed polymer base coat；Be subsequently placed in that 100mL mass percent concentrations are 0.01% 4,4 '-Diphenyl disulfide
Reacted 5 hours in the methanol solution of alcohol, reacted pipe is vacuum dried after fully being embathed through methyl alcohol, exists with KJT-1 antibacterial peptides
Horseradish peroxidase and the lower reaction of hydrogen peroxide effect, obtain the fibro-colonoscope of surface bond antibacterial polypeptide, are named as
KJT-1 fibro-colonoscopes.
According to the method described above, KJT-2~7 fibro-colonoscope is prepared respectively.
The compliance test result of the antibacterial peptide of embodiment 2
It is 2mg/ml that KJT-1~7 polypeptide distilled water is dissolved into concentration, and antibacterial activity is carried out using agar diffusion method
Detection.The bacterial strain used in agar diffusion method is Listeria monocytogenes, vibrio parahemolyticus, campylobacter jejuni, small
Yersinia enterocolitica, staphylococcus aureus, clostridium botulinum, C.perfringens, proteus, brucella, intestines
Enterohemorrhagic E.coli 0157:The combination of H7, Yersinia ruckeri and comma bacillus.After strain culturing, 50 microlitres of bacterium solutions are taken respectively
Coat LB solid mediums.After standing band bacterium solution absorption, the polypeptide solution that concentration is 200ppm is separately added into.37 DEG C of cultures 1
After hour, the presence or absence of inhibition zone and size are observed.The results are shown in Table 1.
The polypeptide Analysis of Antimicrobial Activity result of table 1
7 described polypeptides all have larger inhibition zone.The effect of the suppression pathogenic entero becteria having had in a short time
Really.
The hemolytic activity of the antibacterial peptide of embodiment 3
Collection people or the new blood lmL of rabbit, are dissolved into PBS solution after anticoagulant heparin, I000g centrifugation 5min, receive
Collection red blood cell；Washed with PBS 3 times, then it is resuspended with I0ml PBS；Take 100 μ L red cell suspensions and 100 μ L PBS dissolvings not
It is well mixed with the antibacterial peptide solution of concentration, the constant-temperature incubation Ih in 37 DEG C of incubators；Taken out after Ih, 4 DEG C of 1000g centrifugations
5min；Take out supernatant ELIASA light-metering absorption value at 540nm；Every group is averaged, and comparative analysis.Wherein 100 μ
1PBS is used as negative control；100 μ 10.2%Tritonx-100 are used as positive control.Result finds that 7 antibacterial peptides exist respectively
There is no the haemolysis imagination under the concentration of 2000 micrograms/ml, with great application space.
The antibiotic property detection of fibro-colonoscope of the embodiment 4 containing polypeptides coating
7 kinds of fibro-colonoscopes that embodiment 1 is prepared and the fibro-colonoscope without polypeptides coating, give respectively
With EHEC 0157:H7 positive intestines problem patient uses, after use, by conventional cleaning and sterilization side
Formula is cleaned.Afterwards, in aseptic environment, fibro-colonoscope surfaces externally and internally is respectively placed in PBS water environments and is shaken, is rushed
30min is washed, then by bacteriological filtration membrane filtration water body, bacteriological filtration film surface is rinsed with culture medium, 37 degrees Celsius of culture 24h, afterwards
Detection finds, using not detecting EHEC 0157 in 7 kinds of gastroscopes that embodiment 1 is prepared:H7 is thin
The presence of bacterium, without detecting EHEC 0157 in the fibro-colonoscope of polypeptides coating:The presence of H7, it is total to cause
Germ bacterium number amounts to 35.This also illustrates that polypeptides coating has preferably suppress what bacterium remained in general fibre Sigmoidoscope
Function.
Coating prepared by other several bacterium uses other several pathogens：Yersinia ruckeri and comma bacillus carry out above-mentioned same
The inspection of sample, as a result shows the presence for not detecting pathogen in the fibro-colonoscope containing antibacterial peptide coating.
It is above specific embodiment of the invention, its role is to be further described in detail to present disclosure,
Reader is more readily understood, but is not constituted to protection of the presently claimed invention.
Sequence table
The ＞ Nanchang Qing Nang traditional Chinese medicines Co., Ltds of ＜ 110
A kind of medical fibre Sigmoidoscopes of the ＞ of ＜ 120 and preparation method thereof
〈210〉1
〈211〉27
〈212〉PRT
〈400〉KJT1
NTIWIPRRPHWQYWSQHWNTSPMTGLR
〈210〉2
〈211〉27
〈212〉PRT
〈400〉KJT2
QFFLQCGGGWVCSAHAWWMTRWWSQQR；
〈210〉3
〈211〉26
〈212〉PRT
〈400〉KJT3
WKHWGTIILNYEFRMNIAECFSGHDS；
〈210〉4
〈211〉27
〈212〉PRT
〈400〉KJT4
RLTWYPIYPMCHWCASAMYQYHHWLHQ；
〈210〉5
〈211〉27
〈212〉PRT
〈400〉KJT5
LSQVPGFIPMTHTRLQWLPVGPDQTRS；
〈210〉6
〈211〉27
〈212〉PRT
〈400〉KJT6
DRQHAATAQSLSLQYARFLVSWEQNNQ；
〈210〉7
〈211〉27
〈212〉PRT
〈400〉KJT7
RIEYHHNQYVTDVCSWQHKWDERGPWP；
Claims (4)
1. a kind of medical fibre Sigmoidoscope, including fibro-colonoscope body, it is characterised in that：The interior appearance of the fibro-colonoscope
Face is coated with antibacterial peptide slow release layer.
2. the medical fibre Sigmoidoscope as shown in claim 1, the sequence of the antibacterial peptide in the antibacterial peptide slow release layer is SEQ
ID NO：Shown in 1-7 is any.
3. a kind of antibacterial peptide, it is characterised in that：Its sequence such as SEQ ID NO：Shown in 1-7 is any.
4. application of the polypeptide described in claim 3 in being used to prepare medical fibre Sigmoidoscope as antibacterial peptide slow release layer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710088129.6A CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710088129.6A CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106859585A true CN106859585A (en) | 2017-06-20 |
| CN106859585B CN106859585B (en) | 2018-11-30 |
Family
ID=59166350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710088129.6A Expired - Fee Related CN106859585B (en) | 2017-02-19 | 2017-02-19 | A kind of medical fibre Sigmoidoscope and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106859585B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120035437A1 (en) * | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Navigation of a lumen traveling device toward a target |
| CN106037619A (en) * | 2016-07-08 | 2016-10-26 | 张学军 | Ear-nose-throat endoscope equipment |
| CN106236004A (en) * | 2016-06-20 | 2016-12-21 | 中国人民解放军军事医学科学院附属医院 | A kind of have the gastroscope preventing antibacterial residual function |
-
2017
- 2017-02-19 CN CN201710088129.6A patent/CN106859585B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120035437A1 (en) * | 2006-04-12 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Navigation of a lumen traveling device toward a target |
| CN106236004A (en) * | 2016-06-20 | 2016-12-21 | 中国人民解放军军事医学科学院附属医院 | A kind of have the gastroscope preventing antibacterial residual function |
| CN106037619A (en) * | 2016-07-08 | 2016-10-26 | 张学军 | Ear-nose-throat endoscope equipment |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106859585B (en) | 2018-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thet et al. | Prototype development of the intelligent hydrogel wound dressing and its efficacy in the detection of model pathogenic wound biofilms | |
| Zhao et al. | Understanding bacterial biofilms: From definition to treatment strategies | |
| Traba et al. | Bacteria responsive antibacterial surfaces for indwelling device infections | |
| Molinnus et al. | Towards a flexible electrochemical biosensor fabricated from biocompatible Bombyx mori silk | |
| CN109564213A (en) | Detect wound microbes infection | |
| CN108159486B (en) | Antibacterial and hemostatic dual-function material and preparation method thereof | |
| AU2016287746A1 (en) | Microbiome-compatible cosmetics | |
| Saino et al. | Photodynamic action of Tri-meso (N-methylpyridyl), meso (N-tetradecyl-pyridyl) porphine on Staphylococcus epidermidis biofilms grown on Ti6Al4V alloy | |
| IL263017A (en) | Aqueous biomolecule coupling on co2-plasma-activated surfaces | |
| CN108187119B (en) | Cellulose-based antibacterial hemostatic material and preparation method thereof | |
| Akers et al. | Biofilm formation by clinical isolates and its relevance to clinical infections | |
| CN101405013A (en) | Methods of treating or preventing peritonitis with oxidative reductive potential water solution | |
| Hou et al. | Gram-selective antibacterial peptide hydrogels | |
| Gosztyla et al. | A comparison of sterilization techniques for production of decellularized intestine in mice | |
| Li et al. | Metabolic labeling strategy boosted antibacterial efficiency for photothermal and photodynamic synergistic bacteria-infected wound therapy | |
| Howaili et al. | Development and evaluation of a novel beneficent antimicrobial bioscaffold based on animal waste-fish swim bladder (FSB) doped with silver nanoparticles | |
| Hoffmann et al. | Pseudoepidemic of Rhodotorula rubra in patients undergoing fiberoptic bronchoscopy | |
| Lee et al. | Basic amino acid-mediated cationic amphiphilic surfaces for antimicrobial pH monitoring sensor with wound healing effects | |
| Liu et al. | Multifunctional antibiotics-free hydrogel dressings with self-regulated nitric oxide-releasing kinetics for improving open wound healing | |
| Zhang et al. | Quaternized carbon dots with enhanced antimicrobial ability towards Gram-negative bacteria for the treatment of acute peritonitis caused by E. coli | |
| Zhang et al. | Nanofibrous dressing: Potential alternative for fighting against antibiotic‐resistance wound infections | |
| CN106859585B (en) | A kind of medical fibre Sigmoidoscope and preparation method thereof | |
| CN106236004B (en) | It is a kind of with the gastroscope for preventing bacterium residual function | |
| CN103288924B (en) | Catfish antimicrobial peptide mutant and preparation method thereof | |
| CN115105624B (en) | Marine polysaccharide-based efficient antibacterial film dressing and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Sheng Nan Inventor after: Lei Dongyun Inventor before: Lei Dongyun |
|
| CB03 | Change of inventor or designer information | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20181018 Address after: 272000 Department of Gastroenterology, Jining first people's Hospital, No. 6 health Road, Jining, Shandong Applicant after: Sheng Nan Address before: 330000, 8 floor, Guoli building, 889 Hongdu North Road, East Lake District, Nanchang, Jiangxi. Applicant before: Nanchang young capsule Chinese Medicine Co., Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181130 Termination date: 20190219 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |